Geode Capital Management’s Perspective Therapeutics CATX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.76M | Buy |
|
|||||
|
2025
Q1 | $2.54M | Buy |
|
|||||
|
2024
Q4 | $3.73M | Buy |
|
|||||
|
2024
Q3 | $15.5M | Buy |
|
|||||
|
2024
Q2 | $10.3M | Buy |
|
|||||
|
2024
Q1 | $5.21M | Buy |
|
|||||
|
2023
Q4 | $1.01M | Hold |
|
|||||
|
2023
Q3 | $689K | Buy |
|
|||||
|
2023
Q2 | $1.64M | Buy |
|
|||||
|
2023
Q1 | $1.19M | Buy |
|
|||||
|
2022
Q4 | $282K | Buy |
|
|||||
|
2022
Q3 | $260K | Hold |
|
|||||
|
2022
Q2 | $349K | Buy |
|
|||||
|
2022
Q1 | $406K | Hold |
|
|||||
|
2021
Q4 | $433K | Hold |
|
|||||
|
2021
Q3 | $706K | Hold |
|
|||||
|
2021
Q2 | $892K | Buy |
|
|||||
|
2021
Q1 | $1.07M | Buy |
|
|||||
|
2020
Q4 | $145K | Hold |
|
|||||
|
2020
Q3 | $188K | Hold |
|
|||||
|
2020
Q2 | $179K | Hold |
|
|||||
|
2020
Q1 | $171K | Buy |
|
|||||
|
2019
Q4 | $170K | Buy |
|
|||||
|
2019
Q3 | $86K | Hold |
|
|||||
|
2019
Q2 | $110K | Hold |
|
|||||
|
2019
Q1 | $98K | Hold |
|
|||||
|
2018
Q4 | $80K | Hold |
|
|||||
|
2018
Q3 | $139K | Hold |
|
|||||
|
2018
Q2 | $121K | Hold |
|
|||||
|
2018
Q1 | $113K | Hold |
|
|||||
|
2017
Q4 | $107K | Hold |
|
|||||
|
2017
Q3 | $139K | Hold |
|
|||||
|
2017
Q2 | $168K | Hold |
|
|||||
|
2017
Q1 | $159K | Hold |
|
|||||
|
2016
Q4 | $156K | Hold |
|
|||||
|
2016
Q3 | $194K | Hold |
|
|||||
|
2016
Q2 | $234K | Hold |
|
|||||
|
2016
Q1 | $242 | Hold |
|
|||||
|
2015
Q4 | $252K | Hold |
|
|||||
|
2015
Q3 | $377K | Buy |
|
|||||
|
2015
Q2 | $360K | Hold |
|
|||||
|
2015
Q1 | $382K | Hold |
|
|||||
|
2014
Q4 | $355K | Hold |
|
|||||
|
2014
Q3 | $411K | Hold |
|
|||||
|
2014
Q2 | $760K | Buy |
|
|||||
|
2014
Q1 | $331K | Buy |
|
|||||
|
2013
Q4 | $53K | Hold |
|
|||||
|
2013
Q3 | $70K | Hold |
|
|||||
|
2013
Q2 | $52K | Buy |
|